Free tool
FAERS Monitor: Nicorette
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020066 or its brand name (Nicorette, Nicotine Polacrilex). Reports on generic versions are filed under their own applications.
Reports
36,363
Serious
14,086
39% of reports
Hospitalization
5,332
Death reported
1,717
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective4,769
- nicotine dependence4,064
- intentional drug misuse3,435
- nausea2,816
- malaise1,480
- headache1,255
- dizziness1,244
- drug administration error1,176
- overdose1,129
- vomiting1,050
- product quality issue1,038
- wrong technique in product usage process956
- dyspnoea949
- drug dependence864
- dyspepsia843
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 327 |
| 2005 | 411 |
| 2006 | 1,437 |
| 2007 | 1,747 |
| 2008 | 1,352 |
| 2009 | 1,495 |
| 2010 | 1,492 |
| 2011 | 1,955 |
| 2012 | 2,045 |
| 2013 | 1,575 |
| 2014 | 722 |
| 2015 | 2,088 |
| 2016 | 2,005 |
| 2017 | 1,902 |
| 2018 | 3,011 |
| 2019 | 2,150 |
| 2020 | 1,968 |
| 2021 | 1,800 |
| 2022 | 1,512 |
| 2023 | 1,469 |
| 2024 | 1,433 |
| 2025 | 1,504 |
| 2026 | 963 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,017,796 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| nicotine dependenceSignal | 4,064 | 631.1 | 604.4 | 1,222,353 |
| intentional drug misuseSignal | 3,435 | 113.5 | 109.6 | 320,368 |
| drug administration errorSignal | 1,176 | 23.0 | 21.7 | 23,821 |
| dyspepsiaSignal | 843 | 5.0 | 4.7 | 2,675 |
| product quality issueSignal | 1,038 | 4.4 | 4.2 | 2,767 |
| drug dependenceSignal | 864 | 3.1 | 2.9 | 1,245 |
| overdoseSignal | 1,129 | 3.0 | 2.9 | 1,549 |
| wrong technique in product usage processSignal | 956 | 2.7 | 2.6 | 1,057 |
| drug ineffectiveSignal | 4,769 | 2.1 | 2.0 | 2,908 |
| nauseaSignal | 2,816 | 2.1 | 2.0 | 1,593 |
| malaise | 1,480 | 2.0 | 1.9 | 702 |
| dizziness | 1,244 | 1.4 | 1.4 | 173 |
| vomiting | 1,050 | 1.3 | 1.2 | 71 |
| headache | 1,255 | 1.2 | 1.1 | 28 |
| dyspnoea | 949 | 1.0 | 0.9 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.